Showing 12 of 12 recruiting trials for “Leishmaniasis”
RecruitingNCT07487350 ↗
Recurrent Visceral Leishmaniasis in HIV Co-Infection
Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis
Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis
Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate
Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis with Inhaled Pentamidine Plus Oral Miltefosine
RecruitingNCT06514560 ↗
OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients
Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential Biomarkers
RecruitingNCT05602610 ↗
Clinical Prognostic Score to Predict Relapse in VL
👨⚕️ Saskia van Henten, MD, Institute of Tropical Medicine Antwerp, Antwerp, Belgium📍 1 site📅 Started Feb 2023View details ↗
Randomised Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan
👨⚕️ Koert Ritmeijer, Medecins Sans Frontieres, Netherlands📍 2 sites📅 Started Oct 2022View details ↗
Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly
RecruitingNCT06793111 ↗
Visceral Leishmaniasis in Emilia-Romagna (Leishmania-2019)
👨⚕️ Pierluigi Viale, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 5 sites📅 Started Apr 2020View details ↗
RecruitingNCT00344188 ↗
Diagnosis and Treatment of Leishmania Infections
👨⚕️ Elise M O'Connell, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Nov 2001View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →